214 related articles for article (PubMed ID: 17543345)
1. Cancer immunotherapy, mathematical modeling and optimal control.
Castiglione F; Piccoli B
J Theor Biol; 2007 Aug; 247(4):723-32. PubMed ID: 17543345
[TBL] [Abstract][Full Text] [Related]
2. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
Castiglione F; Piccoli B
Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930
[TBL] [Abstract][Full Text] [Related]
3. Determination of the optimal therapeutic protocols in cancer immunotherapy.
Cappuccio A; Castiglione F; Piccoli B
Math Biosci; 2007 Sep; 209(1):1-13. PubMed ID: 17416392
[TBL] [Abstract][Full Text] [Related]
4. Computational modeling of the immune response to tumor antigens.
Castiglione F; Toschi F; Bernaschi M; Succi S; Benedetti R; Falini B; Liso A
J Theor Biol; 2005 Dec; 237(4):390-400. PubMed ID: 16039673
[TBL] [Abstract][Full Text] [Related]
5. [Trends in colorectal cancer vaccination].
Mocellin S; Campana LG
Recenti Prog Med; 2005; 96(7-8):338-43. PubMed ID: 16209113
[TBL] [Abstract][Full Text] [Related]
6. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines.
Chekhun VF
Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
[No Abstract] [Full Text] [Related]
8. Dendritic cells and their role in cancer immunotherapy.
Jalili A
Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
[TBL] [Abstract][Full Text] [Related]
9. Suppressive influences in the immune response to cancer.
Bronte V; Mocellin S
J Immunother; 2009 Jan; 32(1):1-11. PubMed ID: 19307988
[TBL] [Abstract][Full Text] [Related]
10. Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy.
Kiran KL; Lakshminarayanan S
Biosystems; 2010 Aug; 101(2):117-26. PubMed ID: 20639123
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic cancer vaccines: an emerging treatment option.
King SE
Clin J Oncol Nurs; 2004 Jun; 8(3):271-8. PubMed ID: 15208821
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic cancer vaccines.
Morris LF; Ribas A
Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
[TBL] [Abstract][Full Text] [Related]
14. The use of dendritic cells in cancer immunotherapy.
Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P
Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
[TBL] [Abstract][Full Text] [Related]
15. Mathematical model of pulsed immunotherapy for superficial bladder cancer.
Bunimovich-Mendrazitsky S; Byrne H; Stone L
Bull Math Biol; 2008 Oct; 70(7):2055-76. PubMed ID: 18716846
[TBL] [Abstract][Full Text] [Related]
16. Optimization of interleukin-21 immunotherapeutic strategies.
Cappuccio A; Elishmereni M; Agur Z
J Theor Biol; 2007 Sep; 248(2):259-66. PubMed ID: 17574601
[TBL] [Abstract][Full Text] [Related]
17. Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function.
Engelhart M; Lebiedz D; Sager S
Math Biosci; 2011 Jan; 229(1):123-34. PubMed ID: 21129386
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell vaccines in melanoma: from promise to proof?
Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy.
Baxevanis CN; Perez SA; Papamichail M
Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
[TBL] [Abstract][Full Text] [Related]
20. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
Ovali E; Dikmen T; Sonmez M; Yilmaz M; Unal A; Dalbasti T; Kuzeyli K; Erturk M; Omay SB
J Exp Clin Cancer Res; 2007 Jun; 26(2):209-14. PubMed ID: 17725100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]